On October 16–17, 2026, the Third Academic Conference of the Genitourinary Radiology Section of the Polish Society of Radiology was successfully held in Zielona Góra, Poland.

Focused on imaging of the female pelvis and urinary system, the conference brought together multidisciplinary experts in radiology, gynecology, urology, and oncology. Participants discussed advances in pelvic imaging diagnosis, endometriosis, and innovative diagnostic and treatment technologies for gynecological diseases. PRO HITU MEDICAL attended the conference with its PRO HIFU non-invasive focused ultrasound treatment technology. Together with its local partner, Solve Medical, the company explored the prospects for the clinical application of non-invasive treatments in Europe with medical professionals from across the region.

The conference focused on innovations in imaging assessment and treatment strategies for female pelvic and urinary tract disorders, providing a platform for multidisciplinary medical exchange between China and Europe. Prof. C. J. Jeng, an internationally recognized HIFU expert from Taiwan, China, was specially invited to share his clinical experience with European radiologists and gynecologists. His presentation highlighted the clinical practice and value of high-intensity focused ultrasound (HIFU) in treating benign gynecological conditions, including uterine fibroids and adenomyosis, and presented clinical outcomes of non-invasive, uterus-preserving treatment approaches. The session prompted lively discussions among attending specialists.

During the exhibition and networking sessions, PRO HITU MEDICAL and its Polish partner, Solve Medical, introduced participating radiologists and gynecologists to the principles of PRO HIFU focused ultrasound technology, its clinical indications, and the advantages of the equipment. The two parties engaged in in-depth discussions on clinical needs in European gynecology, pathways for implementing non-invasive treatments, and clinical cases. They also explored approaches to promoting the clinical adoption of non-invasive HIFU therapy in the European market, further strengthening PRO HITU MEDICAL’s academic partnerships across Europe.

As a high-tech enterprise specializing in non-invasive focused ultrasound treatment, PRO HITU MEDICAL continues to advance international academic exchange and the clinical adoption of HIFU technology. Participation in this academic conference in Poland marked an important step in expanding the company’s European academic network and showcasing advances in non-invasive medical technology from China.

Looking ahead, PRO HITU MEDICAL will continue to strengthen collaboration with medical experts and overseas partners worldwide, promote the global clinical application of non-invasive focused ultrasound technology, and provide women around the world with new, safe, and non-invasive options for diagnosis and treatment.